{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:27:46Z","timestamp":1793363266379,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13052-018-0477-x","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T04:24:49Z","timestamp":1522815889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?"],"prefix":"10.1186","volume":"44","author":[{"given":"Claudia","family":"Santoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Piluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cinalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Striano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Bravaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silverio","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"477_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00019052-200404000-00004","volume":"17","author":"D Arun","year":"2004","unstructured":"Arun D, Gutmann DH. Recent advances in neurofibromatosis type 1. Curr Opin Neurol. 2004;17:101\u20135.","journal-title":"Curr Opin Neurol"},{"key":"477_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a010118","volume":"151","author":"SA Rasmussen","year":"2000","unstructured":"Rasmussen SA, Friedman JM. NF1 gene and neurofibromatosis 1. Am J Epidemiol. 2000;151:33\u201340.","journal-title":"Am J Epidemiol"},{"key":"477_CR3","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1212\/WNL.54.8.1646","volume":"54","author":"K De Bella","year":"2000","unstructured":"De Bella K, Poskitt K, Szudek J, Friedman JM. Use of \u201cunidentified bright objects\u201d on MRI for diagnosis of neurofibromatosis 1 in children. Neurology. 2000;54:1646\u201351.","journal-title":"Neurology"},{"key":"477_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0887-8994(02)00403-4","volume":"27","author":"J Szudek","year":"2002","unstructured":"Szudek J, Friedman JM. Unidentified bright objects associated with features of neurofibromatosis 1. Pediatr Neurol. 2002;27:123\u20137.","journal-title":"Pediatr Neurol"},{"key":"477_CR5","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s00247-006-0267-2","volume":"36","author":"DS Gill","year":"2006","unstructured":"Gill DS, Hyman SL, Steinberg A, North KN. Age-related findings on MRI in neurofibromatosis type 1. Pediatr Radiol. 2006;36:1048\u201356.","journal-title":"Pediatr Radiol"},{"key":"477_CR6","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1542\/peds.104.4.e49","volume":"104","author":"PD Griffiths","year":"1999","unstructured":"Griffiths PD, Blaser S, Mukonoweshuro W, Armstrong D, Milo-Mason G, Cheung S. Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics. 1999;104:e49.","journal-title":"Pediatrics"},{"key":"477_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0720-048X(97)00088-0","volume":"26","author":"F Menor","year":"1998","unstructured":"Menor F, Marti-Bonmati L, Arana E, Poyatos C, Cortina H. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings. Eur J Radiol. 1998;26:121\u201331.","journal-title":"Eur J Radiol"},{"key":"477_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/jmg.35.10.813","volume":"35","author":"VM Park","year":"1998","unstructured":"Park VM, Pivnick EK. Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients. J Med Genet. 1998;35:813\u201320.","journal-title":"J Med Genet"},{"issue":"Pt 6","key":"477_CR9","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","volume":"111","author":"SM Huson","year":"1988","unstructured":"Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-East Wales. Brain. 1988;111(Pt 6):1355\u201381.","journal-title":"Brain"},{"key":"477_CR10","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1111\/epi.12348","volume":"54","author":"AP Ostendorf","year":"2013","unstructured":"Ostendorf AP, Gutmann DH, Weisenberg JL. Epilepsy in individuals with neurofibromatosis type 1. Epilepsia. 2013;54:1810\u20134.","journal-title":"Epilepsia"},{"key":"477_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fneur.2017.00087","volume":"8","author":"CE Stafstrom","year":"2017","unstructured":"Stafstrom CE, Staedtke V, Comi AM. Epilepsy mechanisms in Neurocutaneous disorders: tuberous sclerosis complex, Neurofibromatosis type 1, and Sturge-weber syndrome. Front Neurol. 2017;8:87.","journal-title":"Front Neurol"},{"key":"477_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.seizure.2011.04.016","volume":"20","author":"HY Hsieh","year":"2011","unstructured":"Hsieh HY, Fung HC, Wang CJ, Chin SC, Wu T. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects. Seizure. 2011;20:606\u201311.","journal-title":"Seizure"},{"key":"477_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.yebeh.2017.05.011","volume":"73","author":"A Pecoraro","year":"2017","unstructured":"Pecoraro A, Arehart E, Gallentine W. Epilepsy in neurofibromatosis type 1. Epilepsy Behav. 2017;73:137\u201341.","journal-title":"Epilepsy Behav"},{"key":"477_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0887-8994(98)00075-7","volume":"19","author":"K Kulkantrakorn","year":"1998","unstructured":"Kulkantrakorn K, Geller TJ. Seizures in neurofibromatosis 1. Pediatr Neurol. 1998;19:347\u201350.","journal-title":"Pediatr Neurol"},{"key":"477_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/08830738030180050501","volume":"18","author":"R Vivarelli","year":"2003","unstructured":"Vivarelli R, Grosso S, Calabrese F, et al. Epilepsy in neurofibromatosis 1. J Child Neurol. 2003;18:338\u201342.","journal-title":"J Child Neurol"},{"key":"477_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0140-6736(78)91804-4","volume":"2","author":"M Miller","year":"1978","unstructured":"Miller M, Hall JG. Possible maternal effect on severity of neurofibromatosis. Lancet. 1978;2:1071\u20133.","journal-title":"Lancet"},{"key":"477_CR17","first-page":"386","volume":"79","author":"VM Riccardi","year":"1987","unstructured":"Riccardi VM, Wald JS. Discounting an adverse maternal effect on severity of neurofibromatosis. Pediatrics. 1987;79:386\u201393.","journal-title":"Pediatrics"},{"key":"477_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.phrs.2016.03.039","volume":"107","author":"R Citraro","year":"2016","unstructured":"Citraro R, Leo A, Constanti A, Russo E, De Sarro G. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis. Pharmacol Res. 2016;107:333\u201343.","journal-title":"Pharmacol Res"},{"key":"477_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/jdv.13356","volume":"30","author":"K Sadowski","year":"2016","unstructured":"Sadowski K, Kotulska K, Schwartz RA, Jozwiak S. Systemic effects of treatment with mtor inhibitors in tuberous sclerosis complex: a comprehensive review. J Eur Acad Dermatol Venereol. 2016;30:586\u201394.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"477_CR20","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1073\/pnas.0503224102","volume":"102","author":"CM Johannessen","year":"2005","unstructured":"Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K. Proc Natl Acad Sci U S A. 2005;102:8573\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"477_CR21","unstructured":"Neurofibromatosis. Conference statement. National Institutes of Health consensus development conference. Arch Neurol. 1988;45:575\u20138."},{"key":"477_CR22","doi-asserted-by":"crossref","unstructured":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the commission on classification and terminology of the international league against epilepsy. Epilepsia. 1981;22:489\u2013501.","DOI":"10.1111\/j.1528-1157.1981.tb06159.x"},{"key":"477_CR23","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-IV","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. Washington: American Psychiatric Association; 1994.","edition":"4"},{"key":"477_CR24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1528-1157.1993.tb00437.x","volume":"34","author":"BR Korf","year":"1993","unstructured":"Korf BR, Carrazana E, Holmes GL. Patterns of seizures observed in association with neurofibromatosis 1. Epilepsia. 1993;34:616\u201320.","journal-title":"Epilepsia"},{"key":"477_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475\u201382.","journal-title":"Epilepsia"},{"key":"477_CR26","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/ajmg.a.38212","volume":"173","author":"C Santoro","year":"2017","unstructured":"Santoro C, Di Rocco F, Kossorotoff M, Zerah M, Boddaert N, Calmon R, et al. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience. Am J Med Genet A. 2017;173:1521\u201330.","journal-title":"Am J Med Genet A"},{"key":"477_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.wneu.2017.08.053","volume":"107","author":"J Roth","year":"2017","unstructured":"Roth J, Ber R, Wisoff JH, Hidalgo ET, Limbrick DD, Berger DS, et al. Endoscopic third Ventriculostomy in patients with Neurofibromatosis type 1: a multicenter international experience. World Neurosurg. 2017 Nov;107:623\u20139.","journal-title":"World Neurosurg"},{"key":"477_CR28","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ejhg.2015.93","volume":"23","author":"C Santoro","year":"2015","unstructured":"Santoro C, Maietta A, Giugliano T, Melis D, Perrotta S, Nigro V, et al. Arg(1809) substitution in neurofibromin: further evidence of a genotype-phenotype correlation in neurofibromatosis type 1. Eur J Hum Genet. 2015;23:1460\u20131.","journal-title":"Eur J Hum Genet"},{"key":"477_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.14581\/jer.13007","volume":"3","author":"HM Jang","year":"2013","unstructured":"Jang HM, Park HR, Mun JK, Hwang KJ, Kim J, Hong SC, et al. Surgical treatment of mesial temporal lobe epilepsy in a patient with neurofibromatosis type 1. J Epilepsy Res. 2013;3:35\u20138.","journal-title":"J Epilepsy Res"},{"key":"477_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.eplepsyres.2013.02.021","volume":"105","author":"C Barba","year":"2013","unstructured":"Barba C, Jacques T, Kahane P, Polster T, Isnard J, Leijten FS, et al. Epilepsy surgery in Neurofibromatosis type 1. Epilepsy Res. 2013;105:384\u201395.","journal-title":"Epilepsy Res"},{"key":"477_CR31","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/j.1469-8749.1995.tb11943.x","volume":"37","author":"P Joy","year":"1995","unstructured":"Joy P, Roberts C, North K, de Silva M. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol. 1995;37:906\u201314.","journal-title":"Dev Med Child Neurol"},{"key":"477_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/humu.10299","volume":"23","author":"L Kluwe","year":"2004","unstructured":"Kluwe L, Siebert R, Gesk S, Friedrich RE, Tinschert S, Kehrer-Sawatzki H, et al. Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene. Hum Mutat. 2004;23:111\u20136.","journal-title":"Hum Mutat"},{"key":"477_CR33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/cge.12187","volume":"85","author":"R Van Minkelen","year":"2014","unstructured":"Van Minkelen R, van Bever Y, Kromosoeto JN, Withagen-Hermans CJ, Nieuwlaat A, Halley DJ, et al. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands. Clin Genet. 2014;85:318\u201327.","journal-title":"Clin Genet"},{"key":"477_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/jmg.2003.014761","volume":"41","author":"M Venturin","year":"2004","unstructured":"Venturin M, Guarnieri P, Natacci F, Stabile M, Tenconi R, Clementi M, et al. Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet. 2004;41:35\u201341.","journal-title":"J Med Genet"},{"key":"477_CR35","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/brain\/awu373","volume":"138","author":"SF Miller-Delaney","year":"2015","unstructured":"Miller-Delaney SF, Bryan K, Das S, McKiernan RC, Bray IM, Reynolds JP, et al. Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy. Brain. 2015;138:616\u201331.","journal-title":"Brain"},{"key":"477_CR36","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.1244193","volume":"342","author":"CL Tan","year":"2013","unstructured":"Tan CL, Plotkin JL, Veno MT, von Schimmelmann M, Feinberg P, Mann S, et al. MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science. 2013;342:1254\u20138.","journal-title":"Science"},{"key":"477_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/dmcn.12044","volume":"55","author":"AM Van Eeghen","year":"2013","unstructured":"Van Eeghen AM, Pulsifer MB, Merker VL, Neumeyer AM, van Eeghen EE, Thibert RL, et al. Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach. Dev Med Child Neurol. 2013;55:146\u201353.","journal-title":"Dev Med Child Neurol"},{"key":"477_CR38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1684\/epd.2015.0736","volume":"17","author":"P Camfield","year":"2015","unstructured":"Camfield P, Camfield C. Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord. 2015;17:117\u201323.","journal-title":"Epileptic Disord"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-018-0477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13052-018-0477-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-018-0477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T18:28:20Z","timestamp":1720204100000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-018-0477-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1186\/s13052-018-0477-x","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"31 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An ethical approval from the local committee of Luigi Vanvitelli\u2019s University of Studies of Campania was achieved., Informed consent forms to participate were collected for each Patients, or patients\u2019 parents or tutors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients, or patients\u2019 parents or tutors, informed consent forms to participate, and for publication, were collected for each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"41"}}